On Tuesday, Shares of CYS Investments, Inc. (NYSE:CYS), dropped -1.31% to $9.07.
CYS Investments, declared financial results for the quarter ended March 31, 2015.
First Quarter 2015 Summary Results
- March 31, 2015 book value per common share of $10.53, after declaring a $0.30 dividend per common share on March 9, 2015.
- GAAP net income accessible to common shareholders of $49.4 million, or $0.31 per diluted common share.
- Core earnings plus drop income of $46.9 million ($32.8 million core earnings and $14.1 million drop income), or $0.30 per diluted common share ($0.21 core earnings and $0.09 drop income).
- Interest rate spread net of hedge counting drop income of 1.44%.
- Operating expenses of 1.16% of average stockholders’ equity.
- Weighted average amortized cost of Agency RMBS and U.S. Treasuries (collectively, “Debt Securities”) of $104.04.
- March 31, 2015 leverage ratio of 6.77 to 1.
- Constant Prepayment Rate (“CPR”) of 10.3%.
- The Company’s duration gap was 0.60 at March 31, 2015.
- The Company’s captive insurance partner CYS Insurance Services, LLC was granted membership in the Federal Home Loan Bank of Cincinnati.
- Repurchased 4,149,571 shares of the Company’s common stock at a weighted-average purchase price of $8.95 for an aggregate of about $37.2 million.
CYS Investments, Inc., a specialty finance company, invests in residential mortgage pass-through securities in the United States. It also focuses on investing in residential mortgage-backed securities that are issued and the principal and interest of which are guaranteed by a federally chartered corporation (Agency RMBS).
Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD), declined -1.28% to $2.31, during its last trading session.
Advanced Micro Devices, declared that Senior Vice President and Chief Financial Officer Devinder Kumar will present at the Jefferies 2015 Global Technology, Media and Telecom Conference at 10:00 a.m. EDT on Wednesday, May 13, 2015 in Miami.
Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. The company’s products primarily comprise x86 microprocessors as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs), and semi-custom System-on-Chip (SoC) products.
At the end of Tuesday’s trade, Shares of Iconix Brand Group, Inc. (NASDAQ:ICON), dwindled -1.17% to $26.93.
Iconix Brand Group, will issue its first quarter ended March 31, 2015 financial results before the market opens on Wednesday, April 29, 2015.
Iconix Brand Group, Inc., a brand administration company, owns, licenses, and markets a portfolio of consumer brands across women’s, men’s, entertainment, and home primarily in the United States and internationally.
Finally, Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), ended its last trade with -1.02% loss, and closed at $12.15.
Merrimack Pharmaceuticals, declared that the company will hold its First Quarter 2015 Investor Conference Call and webcast at 4:30 p.m., Eastern Time, on Thursday, May 7, 2015. Merrimack also declared it will present at the Credit Suisse 2015 Antibody Conference on Wednesday, May 6, 2015 at 10:55 a.m., Eastern Time, in New York.
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
